TABLE 1.
Monkey | Inoculation route and dose (PFU) | Outcome | Viremiaa | Virus in liverb | Antibody responsec |
---|---|---|---|---|---|
Rh-iv3 | i.v., 103 | Died | 1.0 × 106 | 5.5 × 105 | <2 (E), negative (N) |
Rh-iv6 | i.v., 106 | Died | 1.2 × 107 | 1.0 × 108 | <2 (E), negative (N) |
Rh-ig6a | i.g., 106 | Survived | PCR negative | PCR negative | <2 (E), negative (N) |
Rh-ig6b | i.g., 106 | Survived | PCR negative | PCR negative | <2 (E), negative (N) |
Rh-ig7a | i.g., 107 | Survived | PCR negative | PCR negative | <2 (E), negative (N) |
Rh-ig7b | i.g., 107 | Illness and full recovery | 8.8 × 104 | PCR positive and negatived | 7.2 (E), 3.1 (N) |
For Rh-iv3 and Rh-iv6, viremia on day of death is shown (in PFU per milliliter). For Rh-ig7b, viremia was detected on day 28 p.i. and was not detectable by plaque assay and RT-PCR on day 42 and later.
RT-PCR was performed with RNA samples extracted from livers of Rh-iv3 and Rh-iv6 on the day of death and from Rh-ig6a and Rh-ig6b on day 28, when the animals were sacrificed. For Rh-ig7a and Rh-ig7b, biopsies were performed before the infection and at weeks 4 and 11 p.i. Titers are in PFU per gram of tissue.
Antibody response was evaluated in ELISA (E) and in plaque reduction neutralization assay (N) and expressed as 1/log10 of the final serum dilution (see Materials and Methods for details).
Rh-ig7b was RT-PCR negative for virus before infection and at weeks 2 and 6 after infection and was RT-PCR positive at week 4 after infection.